Alexandra Chisholm
About Me
Currently, I work as a postdoctoral fellow at the Icahn School of Medicine at Mount Sinai under the supervision Dr. Yasmin Hurd where I am investigating the neural mechanisms by which cannabidiol (CBD) reduces relapse to opiates. I utilize a multi-pronged approach combining in vivo region specific and cell type specific projection imaging with RNA (bulk and single cell) combined with ATAC sequencing to characterize the molecular transcriptome and epigenome associated with opioid relapse prior to and following treatment with cannabidiol.
Language
English
Position
POSTDOCTORAL FELLOW | Psychiatry
Research Topics
Addiction, Brain, Computational Neuroscience, Epigenetics, Neurobiology, Neurotransmitters, Opioid/Cannabinoid Receptors, Proteomics, RNA, Synaptic Plasticity, Translational Research
Education
PhD, Concordia University
Awards
2021
FRQNT Postdoctoral Fellowship
Fonds de recherche du Québec – Nature et technologies (FRQNT)
2017
NSERC Doctoral Scholarship (PGS-D)
Natural Sciences and Engineering Research Council of Canada
2015
NSERC Master's Scholarship (CGS-M)
Natural Sciences and Engineering Research Council of Canada
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. CHISHOLM has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.